EP2894242B1 - Guest-compound-enveloping polymer-metal-complex crystal, method for producing same, method for preparing crystal structure analysis sample, and method for determining molecular structure of organic compound - Google Patents
Guest-compound-enveloping polymer-metal-complex crystal, method for producing same, method for preparing crystal structure analysis sample, and method for determining molecular structure of organic compound Download PDFInfo
- Publication number
- EP2894242B1 EP2894242B1 EP13835833.8A EP13835833A EP2894242B1 EP 2894242 B1 EP2894242 B1 EP 2894242B1 EP 13835833 A EP13835833 A EP 13835833A EP 2894242 B1 EP2894242 B1 EP 2894242B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- polymer
- metal complex
- crystal
- compound
- pores
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000013078 crystal Substances 0.000 title claims description 397
- 150000002894 organic compounds Chemical class 0.000 title claims description 147
- 238000004458 analytical method Methods 0.000 title claims description 125
- 238000000034 method Methods 0.000 title claims description 80
- 238000004519 manufacturing process Methods 0.000 title claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 174
- 239000011148 porous material Substances 0.000 claims description 157
- 239000002904 solvent Substances 0.000 claims description 135
- 239000003446 ligand Substances 0.000 claims description 69
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 66
- 229910021645 metal ion Inorganic materials 0.000 claims description 37
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 27
- -1 alicyclic hydrocarbon Chemical class 0.000 claims description 27
- 125000000962 organic group Chemical group 0.000 claims description 26
- 238000002425 crystallisation Methods 0.000 claims description 25
- 230000008025 crystallization Effects 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 23
- 239000002184 metal Substances 0.000 claims description 22
- 229910052751 metal Inorganic materials 0.000 claims description 22
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 21
- 125000003118 aryl group Chemical group 0.000 claims description 20
- 239000004215 Carbon black (E152) Substances 0.000 claims description 18
- 125000004432 carbon atom Chemical group C* 0.000 claims description 18
- 229930195733 hydrocarbon Natural products 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 17
- 230000005484 gravity Effects 0.000 claims description 15
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 12
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 11
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims description 10
- 150000008282 halocarbons Chemical class 0.000 claims description 10
- 150000002148 esters Chemical class 0.000 claims description 9
- 230000014509 gene expression Effects 0.000 claims description 9
- 239000012535 impurity Substances 0.000 claims description 9
- 239000012442 inert solvent Substances 0.000 claims description 9
- 150000002825 nitriles Chemical class 0.000 claims description 9
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 claims description 8
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 7
- 238000004811 liquid chromatography Methods 0.000 claims description 7
- 239000008096 xylene Substances 0.000 claims description 7
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 claims description 6
- 230000005855 radiation Effects 0.000 claims description 6
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 claims description 5
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 claims description 5
- 229930014626 natural product Natural products 0.000 claims description 5
- 229910052727 yttrium Inorganic materials 0.000 claims description 3
- 150000001450 anions Chemical class 0.000 claims description 2
- 239000000523 sample Substances 0.000 description 91
- 239000000243 solution Substances 0.000 description 83
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 57
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 51
- UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 description 48
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 42
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 36
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 36
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 28
- 238000000921 elemental analysis Methods 0.000 description 25
- 229910052757 nitrogen Inorganic materials 0.000 description 22
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 19
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 18
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 18
- 229910052739 hydrogen Inorganic materials 0.000 description 18
- 238000003786 synthesis reaction Methods 0.000 description 18
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 14
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 14
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- 239000011800 void material Substances 0.000 description 12
- 239000003960 organic solvent Substances 0.000 description 11
- ULSUXBXHSYSGDT-UHFFFAOYSA-N tangeretin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 ULSUXBXHSYSGDT-UHFFFAOYSA-N 0.000 description 11
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 9
- 238000002447 crystallographic data Methods 0.000 description 9
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 9
- 239000012488 sample solution Substances 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 239000003905 agrochemical Substances 0.000 description 7
- 238000007654 immersion Methods 0.000 description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- XJHDMGJURBVLLE-BOCCBSBMSA-N alpha-santonin Chemical compound C([C@]1(C)CC2)=CC(=O)C(C)=C1[C@@H]1[C@@H]2[C@H](C)C(=O)O1 XJHDMGJURBVLLE-BOCCBSBMSA-N 0.000 description 6
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 6
- 150000001491 aromatic compounds Chemical class 0.000 description 6
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 6
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 6
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 6
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- OHZAHWOAMVVGEL-UHFFFAOYSA-N 2,2'-bithiophene Chemical compound C1=CSC(C=2SC=CC=2)=C1 OHZAHWOAMVVGEL-UHFFFAOYSA-N 0.000 description 5
- 239000005212 4-Cyano-4'-pentylbiphenyl Substances 0.000 description 5
- HHPCNRKYVYWYAU-UHFFFAOYSA-N 4-cyano-4'-pentylbiphenyl Chemical group C1=CC(CCCCC)=CC=C1C1=CC=C(C#N)C=C1 HHPCNRKYVYWYAU-UHFFFAOYSA-N 0.000 description 5
- 229910001429 cobalt ion Inorganic materials 0.000 description 5
- 150000002500 ions Chemical group 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 4
- SLGBZMMZGDRARJ-UHFFFAOYSA-N Triphenylene Natural products C1=CC=C2C3=CC=CC=C3C3=CC=CC=C3C2=C1 SLGBZMMZGDRARJ-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 125000002950 monocyclic group Chemical group 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- 125000005580 triphenylene group Chemical group 0.000 description 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000007872 degassing Methods 0.000 description 3
- 229940116333 ethyl lactate Drugs 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 125000004076 pyridyl group Chemical group 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 2
- CBMYFVSIIYILRH-UHFFFAOYSA-N 2,4,6-tri-4-pyridyl-1,3,5-triazine Chemical compound C1=NC=CC(C=2N=C(N=C(N=2)C=2C=CN=CC=2)C=2C=CN=CC=2)=C1 CBMYFVSIIYILRH-UHFFFAOYSA-N 0.000 description 2
- WCUHJAPMPAPZIF-UHFFFAOYSA-N 4,5,6-tripyridin-4-yltriazine Chemical compound C1=NC=CC(C=2C(=C(C=3C=CN=CC=3)N=NN=2)C=2C=CN=CC=2)=C1 WCUHJAPMPAPZIF-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- XPDWGBQVDMORPB-UHFFFAOYSA-N Fluoroform Chemical compound FC(F)F XPDWGBQVDMORPB-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UUIQMZJEGPQKFD-UHFFFAOYSA-N Methyl butyrate Chemical compound CCCC(=O)OC UUIQMZJEGPQKFD-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 150000004700 cobalt complex Chemical class 0.000 description 2
- INDBQWVYFLTCFF-UHFFFAOYSA-L cobalt(2+);dithiocyanate Chemical compound [Co+2].[S-]C#N.[S-]C#N INDBQWVYFLTCFF-UHFFFAOYSA-L 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- 229940117389 dichlorobenzene Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 description 2
- OBNCKNCVKJNDBV-UHFFFAOYSA-N ethyl butyrate Chemical compound CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- RZJRJXONCZWCBN-UHFFFAOYSA-N octadecane Chemical compound CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 2
- YLYBTZIQSIBWLI-UHFFFAOYSA-N octyl acetate Chemical compound CCCCCCCCOC(C)=O YLYBTZIQSIBWLI-UHFFFAOYSA-N 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- PGMYKACGEOXYJE-UHFFFAOYSA-N pentyl acetate Chemical compound CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 2
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000003797 solvolysis reaction Methods 0.000 description 2
- 238000012916 structural analysis Methods 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 2
- 238000005979 thermal decomposition reaction Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FIDRAVVQGKNYQK-UHFFFAOYSA-N 1,2,3,4-tetrahydrotriazine Chemical compound C1NNNC=C1 FIDRAVVQGKNYQK-UHFFFAOYSA-N 0.000 description 1
- 125000004958 1,4-naphthylene group Chemical group 0.000 description 1
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- BPIUIOXAFBGMNB-UHFFFAOYSA-N 1-hexoxyhexane Chemical compound CCCCCCOCCCCCC BPIUIOXAFBGMNB-UHFFFAOYSA-N 0.000 description 1
- 125000004959 2,6-naphthylene group Chemical group [H]C1=C([H])C2=C([H])C([*:1])=C([H])C([H])=C2C([H])=C1[*:2] 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229910017048 AsF6 Inorganic materials 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- ZKCBXWISPJSFST-UHFFFAOYSA-N Cc(cc1)ccc1[NH+]([NH-])N Chemical compound Cc(cc1)ccc1[NH+]([NH-])N ZKCBXWISPJSFST-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 description 1
- OPFTUNCRGUEPRZ-QLFBSQMISA-N Cyclohexane Natural products CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- XOBKSJJDNFUZPF-UHFFFAOYSA-N Methoxyethane Chemical compound CCOC XOBKSJJDNFUZPF-UHFFFAOYSA-N 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940006460 bromide ion Drugs 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910001914 chlorine tetroxide Inorganic materials 0.000 description 1
- 229910000001 cobalt(II) carbonate Inorganic materials 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- RKTYLMNFRDHKIL-UHFFFAOYSA-N copper;5,10,15,20-tetraphenylporphyrin-22,24-diide Chemical compound [Cu+2].C1=CC(C(=C2C=CC([N-]2)=C(C=2C=CC=CC=2)C=2C=CC(N=2)=C(C=2C=CC=CC=2)C2=CC=C3[N-]2)C=2C=CC=CC=2)=NC1=C3C1=CC=CC=C1 RKTYLMNFRDHKIL-UHFFFAOYSA-N 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- LMGZGXSXHCMSAA-UHFFFAOYSA-N cyclodecane Chemical compound C1CCCCCCCCC1 LMGZGXSXHCMSAA-UHFFFAOYSA-N 0.000 description 1
- DDTBPAQBQHZRDW-UHFFFAOYSA-N cyclododecane Chemical compound C1CCCCCCCCCCC1 DDTBPAQBQHZRDW-UHFFFAOYSA-N 0.000 description 1
- GPTJTTCOVDDHER-UHFFFAOYSA-N cyclononane Chemical compound C1CCCCCCCC1 GPTJTTCOVDDHER-UHFFFAOYSA-N 0.000 description 1
- WJTCGQSWYFHTAC-UHFFFAOYSA-N cyclooctane Chemical compound C1CCCCCCC1 WJTCGQSWYFHTAC-UHFFFAOYSA-N 0.000 description 1
- 239000004914 cyclooctane Substances 0.000 description 1
- KYTNZWVKKKJXFS-UHFFFAOYSA-N cycloundecane Chemical compound C1CCCCCCCCCC1 KYTNZWVKKKJXFS-UHFFFAOYSA-N 0.000 description 1
- AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical compound CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 description 1
- 125000005265 dialkylamine group Chemical group 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- MJEMIOXXNCZZFK-UHFFFAOYSA-N ethylone Chemical compound CCNC(C)C(=O)C1=CC=C2OCOC2=C1 MJEMIOXXNCZZFK-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 210000003918 fraction a Anatomy 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 229940006461 iodide ion Drugs 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 125000006606 n-butoxy group Chemical group 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001683 neutron diffraction Methods 0.000 description 1
- 229910001453 nickel ion Inorganic materials 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 229940038384 octadecane Drugs 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 239000013110 organic ligand Substances 0.000 description 1
- CFNJLPHOBMVMNS-UHFFFAOYSA-N pentyl butyrate Chemical compound CCCCCOC(=O)CCC CFNJLPHOBMVMNS-UHFFFAOYSA-N 0.000 description 1
- FGPPDYNPZTUNIU-UHFFFAOYSA-N pentyl pentanoate Chemical compound CCCCCOC(=O)CCCC FGPPDYNPZTUNIU-UHFFFAOYSA-N 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Chemical compound [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- DTMHTVJOHYTUHE-UHFFFAOYSA-N thiocyanogen Chemical compound N#CSSC#N DTMHTVJOHYTUHE-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229940102001 zinc bromide Drugs 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D1/00—Processes for applying liquids or other fluent materials
- B05D1/18—Processes for applying liquids or other fluent materials performed by dipping
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/92—Naphthofurans; Hydrogenated naphthofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/54—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/54—Organic compounds
- C30B29/58—Macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
- C30B7/02—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions by evaporation of the solvent
- C30B7/06—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions by evaporation of the solvent using non-aqueous solvents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
- G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
- G01N23/207—Diffractometry using detectors, e.g. using a probe in a central position and one or more displaceable detectors in circumferential positions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/249921—Web or sheet containing structurally defined element or component
Definitions
- the present invention relates to a polymer-metal complex crystal including a guest compound that is useful as a material for preparing a crystal structure analysis sample that is used to determine the molecular structure of a trace amount of organic compound, a method for producing the same, a method for preparing a crystal structure analysis sample that utilizes the polymer-metal complex crystal including a guest compound, and a method for determining the molecular structure of an organic compound that utilizes a crystal structure analysis sample obtained using the method for preparing a crystal structure analysis sample.
- Patent Documents 1 and 2 a physiologically active substance that is derived from a marine organism or the like and found in a trace amount has been expected to be a resource for agricultural chemicals, medicines, and the like. Therefore, it has become very important to accurately and efficiently determine the molecular structure of such a trace amount of organic compound in order to develop a novel agricultural chemical or medicine, for example.
- X-ray single crystal structure analysis has been known as a method for determining the molecular structure of an organic compound.
- the molecular structure of an organic compound can be accurately determined using X-ray single crystal structure analysis when it is possible to prepare a high-quality single crystal.
- p 2592-2605 describes other porous polymer-metal complex including a guest compound such as (ZnI2)3(TPT)2 with anthracene and cyclohexane.
- An object of the invention is to provide a polymer-metal complex crystal including a guest compound that makes it possible to prepare a crystal structure analysis sample that is useful for determining the molecular structure of a trace amount of organic compound, a method for producing the same, a method for preparing a crystal structure analysis sample, and a method for determining the molecular structure of an organic compound that utilizes a crystal structure analysis sample obtained using the method for preparing a crystal structure analysis sample.
- the inventors of the invention conducted extensive studies in order to solve the above technical problem. As a result, the inventors found that a sample that is suitable for crystal structure analysis that is used to determine the molecular structure of a trace amount of organic compound can be efficiently prepared by utilizing a polymer-metal complex crystal including a guest compound that includes a polymer-metal complex having a three-dimensional network structure, and having pores and voids that are three-dimensionally arranged in the three-dimensional network structure in an ordered manner, wherein a specific guest compound is included in the pores and the like in an amount equal to or more than a given amount. This finding has led to the completion of the invention.
- Several aspects of the invention provide the following polymer-metal complex crystal including a guest compound (see [1] to [8]), method for producing a polymer-metal complex crystal including a guest compound (see [10]), method for preparing a crystal structure analysis sample (see [11] to [20]), and a method for determining the molecular structure of an organic compound (see [21]).
- the polymer-metal complex crystal including a guest compound according to one aspect of the invention makes it possible to prepare a crystal structure analysis sample that is useful for determining the molecular structure of a trace amount of organic compound.
- the method for producing a polymer-metal complex crystal including a guest compound according to one aspect of the invention can efficiently produce the polymer-metal complex crystal including a guest compound according to one aspect of the invention.
- the method for preparing a crystal structure analysis sample according to one aspect of the invention can easily and efficiently prepare a crystal structure analysis sample that makes it possible to determine the molecular structure of an organic compound even when the amount of the sample is very small.
- the method for determining the molecular structure of an organic compound according to one aspect of the invention can determine the molecular structure of an organic compound even when the amount of sample is very small.
- a polymer-metal complex crystal including a guest compound, a method for producing a polymer-metal complex crystal including a guest compound, a method for preparing a crystal structure analysis sample, and a method for determining a molecular structure of an organic compound according to exemplary embodiments of the invention are described in detail below.
- a polymer-metal complex crystal including a guest compound includes a polymer-metal complex that includes a ligand having two or more coordinating moieties, and a metal ion that serves as a center metal, the polymer-metal complex having a three-dimensional network structure that is formed by the metal ion and the ligand that is coordinated to the metal ion, and having pores and voids (hereinafter may be referred to as "pores and the like") that are three-dimensionally arranged in the three-dimensional network structure in an ordered manner, at least one compound selected from the group consisting of an aliphatic hydrocarbon, an alicyclic hydrocarbon, an ether, an ester, an aromatic hydrocarbon, a halogenated hydrocarbon, and a nitrile being included in the pores and the voids as a guest compound (A), and the ratio of the amount of the guest compound (A) present in the pores and the voids to the total amount of the guest compound included in the pores and the pores
- the polymer-metal complex used in connection with the embodiments of the invention has a three-dimensional network structure that includes a ligand having two or more coordinating moieties, and a metal ion that serves as a center metal.
- three-dimensional network structure refers to a network-like structure in which a structural unit formed by a ligand (i.e., a ligand having two or more coordinating moieties and an additional monodentate ligand) and a metal ion that is bonded to the ligand is repeatedly arranged three-dimensionally.
- a ligand i.e., a ligand having two or more coordinating moieties and an additional monodentate ligand
- metal ion that is bonded to the ligand is repeatedly arranged three-dimensionally.
- the ligand having two or more coordinating moieties (hereinafter may be referred to as "multidentate ligand”) is not particularly limited as long as the ligand is coordinated to the metal ion to form the three-dimensional network structure.
- a known multidentate ligand may be used as the ligand having two or more coordinating moieties.
- coordinating moiety refers to an atom or an atomic group that is included in the ligand, and has an unshared electron pair that can form a coordination bond.
- the coordinating moiety include a hetero atom such as a nitrogen atom, an oxygen atom, a sulfur atom, and a phosphorus atom; an atomic group such as a nitro group, an amino group, a cyano group, and a carboxyl group; and the like.
- a nitrogen atom and an atomic group that includes a nitrogen atom are preferable.
- the multidentate ligand include an aromatic ring since the planarity of the ligand is improved, and a strong three-dimensional network structure is easily formed.
- a multidentate ligand having two or more coordinating moieties more preferably a multidentate ligand having three coordinating moieties (hereinafter may be referred to as "tridentate ligand"), and still more preferably a tridentate ligand in which the unshared electron pairs (orbitals) of the three coordinating moieties are present in the same plane, and the three coordinating moieties are arranged radially with respect to the center of the tridentate ligand at an equal interval.
- the expression "present in the same plane” used herein includes a case where each unshared electron pair is present in the same plane, and a case where each unshared electron pair is present in a plane that is shifted to some extent (e.g., present in a plane that intersects a reference plane at an angle of 20° or less).
- the expression "the three coordinating moieties are arranged radially with respect to the center of the tridentate ligand at an equal interval” used herein means that the three coordinating moieties are arranged on lines that extend radially from the center of the ligand at an equal interval, at an almost equal distance from the center of the ligand.
- tridentate ligand examples include a ligand represented by the following formula (1).
- Ar is a substituted or unsubstituted trivalent aromatic group
- X 1 to X 3 are independently a divalent organic group, or a single bond that directly bonds Ar and Y 1 , Y 2 , or Y 3
- Y 1 to Y 3 are independently a monovalent organic group having a coordinating moiety.
- Ar in the formula (1) is a trivalent aromatic group.
- the number of carbon atoms of Ar is normally 3 to 22, preferably 3 to 13, and more preferably 3 to 6.
- Ar examples include a trivalent aromatic group having a monocyclic structure that consists of one 6-membered aromatic ring, and a trivalent aromatic group having a fused ring structure in which three 6-membered aromatic rings are fused.
- Examples of the trivalent aromatic group having a monocyclic structure that consists of one 6-membered aromatic ring include the groups respectively represented by the following formulas (2a) to (2d).
- Examples of the trivalent aromatic group having a fused ring structure in which three 6-membered aromatic rings are fused include the group represented by the following formula (2e). Note that "*" in the formulas (2a) to (2e) indicates the positions at which X 1 to X 3 are bonded.
- the aromatic groups represented by the formulas (2a) and (2c) to (2e) may be substituted with a substituent at an arbitrary position.
- a substituent include an alkyl group such as a methyl group, an ethyl group, an isopropyl group, an n-propyl group, and a t-butyl group; an alkoxy group such as a methoxy group, an ethoxy group, an n-propoxy group, and an n-butoxy group; a halogen atom such as a fluorine atom, a chlorine atom, and a bromine atom; and the like.
- Ar is preferably the aromatic group represented by the formula (2a) or (2b), and particularly preferably the aromatic group represented by the formula (2b).
- X 1 to X 3 are independently a divalent organic group, or a single bond that directly bonds Ar and Y 1 , Y 2 , or Y 3 .
- the divalent organic group that may be represented by X 1 to X 3 is preferably a group that can form a pi electron conjugated system together with Ar.
- the divalent organic group that may be represented by X 1 to X 3 forms a pi electron conjugated system, the planarity of the tridentate ligand represented by the formula (1) is improved, and a strong three-dimensional network structure is easily formed.
- the number of carbon atoms of the divalent organic group is preferably 2 to 18, more preferably 2 to 12, and still more preferably 2 to 6.
- Examples of the divalent unsaturated aliphatic group having 2 to 10 carbon atoms include a vinylene group, an acetylene group (ethynylene group), and the like.
- Examples of the divalent organic group having a monocyclic structure that consists of one 6-membered aromatic ring include a 1,4-phenylene group and the like.
- Examples of the divalent organic group having a fused ring structure in which two to four 6-membered aromatic rings are fused include a 1,4-naphthylene group, a 1,5-naphthylene group, a 2,6-naphthylene group, an anthracene-1,4-diyl group, and the like.
- Examples of a combination of two or more divalent organic groups among these divalent organic groups include the groups respectively represented by the following formulas.
- aromatic rings may include a hetero atom such as a nitrogen atom, an oxygen atom, or a sulfur atom in their ring.
- the divalent organic group may be substituted with a substituent.
- substituents include those mentioned above in connection with Ar.
- the groups respectively represented by the following formulas are preferable as the divalent organic group that may be represented by X 1 to X 3 .
- Y 1 to Y 3 are independently a monovalent organic group having a coordinating moiety.
- the organic group represented by Y 1 to Y 3 is preferably a group that can form a pi electron conjugated system together with Ar and X 1 to X 3 .
- the number of carbon atoms of the organic group represented by Y 1 to Y 3 is preferably 5 to 11, and more preferably 5 to 7.
- Examples of the organic group represented by Y 1 to Y 3 include the organic groups respectively represented by the following formulas (3a) to (3f). Note that "*" in the formulas (3a) to (3f) indicates the position at which X 1 , X 2 , or X 3 is bonded.
- the organic groups represented by the formulas (3a) to (3f) may be substituted with a substituent at an arbitrary position.
- substituents include those mentioned above in connection with Ar.
- the group represented by the formula (3a) is particularly preferable as Y 1 to Y 3 .
- the size of the pores and the like of the polymer-metal complex can be adjusted by appropriately selecting Ar, X 1 to X 3 , and Y 1 to Y 3 in the tridentate ligand represented by the formula (1).
- the method according to one embodiment of the invention makes it possible to efficiently obtain a single crystal of a polymer-metal complex that has pores and the like having a size sufficient to include an organic compound for which the molecular structure is to be determined.
- the tridentate ligand represented by the formula (1) have high planarity and high symmetry, and have a structure in which a pi-conjugated system extends over the entire ligand, since a strong three-dimensional network structure is easily formed.
- Examples of such a tridentate ligand include the ligands respectively represented by the following formulas (4a) to (4f).
- TPT 2,4,6-tris(4-pyridyl)-1,3,5-triazine
- the metal ion that serves as the center metal is not particularly limited as long as the metal ion forms a coordination bond together with the multidentate ligand to form the three-dimensional network structure.
- a known metal ion may be used as the metal ion that serves as the center metal. It is preferable to use an ion of a metal among the metals that belong to Groups 8 to 12 in the periodic table, such as an iron ion, a cobalt ion, a nickel ion, a copper ion, a zinc ion, or a silver ion, and more preferably an ion of a divalent metal among the metals that belong to Groups 8 to 12 in the periodic table. It is particularly preferable to use a zinc(II) ion or a cobalt(II) ion, since a polymer-metal complex having large pores and the like can be easily obtained.
- the polymer-metal complex used in connection with the embodiments of the invention is normally stabilized due to coordination of a monodentate ligand that serves as a counter ion in addition to the neutral multidentate ligand.
- Examples of the monodentate ligand include a monovalent anion such as a chloride ion (Cl - ), a bromide ion (Br - ), an iodide ion (I-), and a thiocyanate ion (SCN - ).
- a monovalent anion such as a chloride ion (Cl - ), a bromide ion (Br - ), an iodide ion (I-), and a thiocyanate ion (SCN - ).
- the polymer-metal complex used in connection with the embodiments of the invention may include a solvent; an electrically neutral coordinating compound such as ammonia, a monoalkylamine, a dialkylamine, a trialkylamine, and ethylenediamine; a framework-forming aromatic compound (described below); and the like.
- an electrically neutral coordinating compound such as ammonia, a monoalkylamine, a dialkylamine, a trialkylamine, and ethylenediamine
- a framework-forming aromatic compound described below
- frame-forming aromatic compound refers to an aromatic compound that is restrained within the three-dimensional network structure due to a bond (other than a coordination bond) or interaction, and forms part of the framework of a host molecule (i.e., a compound in which a guest compound can be incorporated).
- a bond other than a coordination bond
- the polymer-metal complex includes the framework-forming aromatic compound, the three-dimensional network structure easily becomes stronger, and may be further stabilized even in a state in which the polymer-metal complex includes the molecule of an organic compound for which the molecular structure is to be determined.
- Examples of the framework-forming aromatic compound include a fused polycyclic aromatic compound.
- Examples of the fused polycyclic aromatic compound include the compounds respectively represented by the following formulas (5a) to (5i).
- the polymer-metal complex used in connection with the embodiments of the invention has the three-dimensional network structure that is formed by the metal ion and the multidentate ligand that is coordinated to the metal ion, and has the pores and the like that are three-dimensionally arranged in the three-dimensional network structure in an ordered manner.
- the pores and the like that are three-dimensionally arranged in the three-dimensional network structure in an ordered manner means that the pores and the like are arranged in the three-dimensional network structure in an ordered manner to such an extent that the pores and the like can be observed by X-ray single crystal structure analysis.
- pore refers to a space defined by the three-dimensional network structure of the polymer-metal complex, such as spaces A and B (see (a) and (b) in FIG. 3 ) that are defined by the three-dimensional network structure, and a space (white area) (see (a) in FIG. 4 ) that is formed between the repeating units of the spherical complex structure (purple area).
- void used herein refers to an internal space of the spherical complex structure, such as the repeating unit (an area enclosed by the red line (see (b) in FIG. 4 ) of the spherical complex structure (see (a) in FIG. 4 ).
- the three-dimensional network structure is not particularly limited as long as the three-dimensional network structure has the above structural features, and the pores and the like have a size sufficient to include the molecule of an organic compound for which the molecular structure is to be determined.
- a polymer-metal complex having relatively large pores and the like is normally obtained when a multidentate ligand is used in which the distance from the center of the ligand to the coordinating moiety is long, and a polymer-metal complex having relatively small pores and the like is normally obtained when a multidentate ligand is used in which the distance from the center of the ligand to the coordinating moiety is short.
- the size of the pore has a correlation with the diameter of a circle that is inscribed to the pore (hereinafter may be referred to as "pore inscribed circle”) in a plane parallel to the crystal plane that is closest to a perpendicular plane with respect to the extension direction of the pore (hereinafter may be referred to as "parallel plane").
- the extension direction of the pore may be determined by the following method.
- a crystal plane X (e.g., plane A, plane B, plane C, or diagonal plane thereof) in an appropriate direction that intersects the target pore is selected.
- the atoms that are present in the crystal plane X and included in the host molecule are represented using the van der Waals radius to draw a cross-sectional view of the pore taken along the crystal plane X.
- a cross-sectional view of the pore taken along a crystal plane Y that is shifted from the crystal plane X by one unit cell is drawn.
- the center of the cross-sectional shape of the pore in the crystal plane X and the center of the cross-sectional shape of the pore in the crystal plane Y are connected using a straight line (dash-dotted line) (see FIG. 1 ).
- the direction of the straight line corresponds to the extension direction of the pore.
- the diameter of the pore inscribed circle may be determined by the following method.
- a cross-sectional view of the pore taken along the parallel plane is drawn in the same manner as described above.
- the pore inscribed circle is drawn using the cross-sectional view, and the diameter of the pore inscribed circle is measured. The measured value is converted into the actual scale to determine the actual diameter of the pore inscribed circle.
- the diameter of the pore inscribed circle in each parallel plane is measured while gradually shifting the parallel plane in parallel by one unit cell to determine the diameter of the smallest inscribed circle and the diameter of the largest inscribed circle.
- the diameter of the pore inscribed circle of the polymer-metal complex used in connection with the embodiments of the invention is preferably 2 to 30 ⁇ , and more preferably 3 to 10 ⁇ .
- the shape of the pore significantly differs from a true circle, it is preferable to predict the guest molecule inclusion capability of the polymer-metal complex from the minor axis and the major axis of the pore inscribed ellipse in the parallel plane.
- the major axis of the pore inscribed ellipse of the polymer-metal complex used in connection with the embodiments of the invention is preferably 2 to 30 ⁇ , and more preferably 3 to 10 ⁇ .
- the minor axis of the pore inscribed ellipse of the polymer-metal complex used in connection with the embodiments of the invention is preferably 2 to 30 ⁇ , and more preferably 3 to 10 ⁇ .
- the pore volume in the polymer-metal complex used in connection with the embodiments of the invention may be calculated using the method described in Acta Crystallogr. A46, 194-201 (1990 ). Specifically, the pore volume in the polymer-metal complex may be calculated using the expression "volume of single crystal ⁇ void ratio in unit cell” based on the solvent accessible void (void volume in unit cell) calculated by a calculation program "PLATON SQUEEZE PROGRAM".
- the pore volume (i.e., the total pore volume in one piece of the single crystal) in the polymer-metal complex used in connection with the embodiments of the invention is preferably 1 ⁇ 10 -7 to 0.1 mm 3 , and more preferably 1 ⁇ 10 -5 to 1 ⁇ 10 -3 mm 3 .
- each spherical complex structure has an internal space (void).
- the size of the void may be calculated using the method described in Acta Crystallogr. A46, 194-201 (1990 ) in the same manner as the pore volume.
- the polymer-metal complex used in connection with the embodiments of the invention does not lose crystallinity, and have relatively large pores and the like even after the guest compound has been introduced into (incorporated in) the pores and the like.
- the polymer-metal complex includes an organic solvent (hereinafter may be referred to as "crystallization solvent”) used when synthesizing the polymer-metal complex in the pores and the like.
- crystal solvent organic solvent
- the resulting polymer-metal complex corresponds to the polymer-metal complex including a guest compound according to one embodiment of the invention.
- the crystallization solvent is not the guest compound (A)
- the crystallization solvent is replaced with the guest compound (A) as described later to obtain a polymer-metal complex including a guest compound that may suitably be used to prepare a crystal structure analysis sample.
- the polymer-metal complex used in connection with the embodiments of the invention is normally obtained by mixing a first solvent solution of the ligand having two or more coordinating moieties and a second solvent solution that includes a metal salt so that the resulting polymer-metal complex includes the ligand and the metal ion in a given ratio.
- the tridentate ligand represented by the formula (1) may be used as the ligand, and a zinc(II) salt such as zinc iodide or zinc bromide, a cobalt(II)salt such as cobalt thiocyanate, or the like may be used as the metal salt. Note that the details of the method for synthesizing the polymer-metal complex are described later.
- polymer-metal complexes respectively represented by the following formulas (6a) to (6d) that are obtained using TPT respectively by the formula (4a) as the tridentate ligand. These polymer-metal complexes are particularly suitable as the polymer-metal complex used in connection with the embodiments of the invention.
- polymer-metal complex 1 examples include [(ZnI 2 ) 3 (TPT) 2 (PhNO 2 ) 5.5 ] n (polymer-metal complex 1) disclosed in JP-A-2008-214584 and J. Am. Chem. Soc. 2004, v. 126, pp. 16292-16293 .
- FIG. 2 illustrates the three-dimensional network structure of the polymer-metal complex 1.
- the three-dimensional network structure of the polymer-metal complex 1 includes three-dimensional network structures 1a and 1b.
- the pyridyl groups of two TPT and two iodide ions are coordinated to each zinc(II) ion to form a tetra-coordinated tetrahedral structure.
- the structures including the zinc(II) ion are three-dimensionally connected by TPT to form each three-dimensional network structure (see (a) in FIG. 2 ).
- the three-dimensional network structures 1a and 1b have a closed cyclic chain structure that consists of ten TPT molecules and ten Zn atoms as the shortest closed cyclic chain structure (see (b) in FIG. 2 ).
- the three-dimensional network structures 1a and 1b are considered to be a helical hexagonal three-dimensional network structure in which the pitch along the (010) axis is 15 ⁇ (see (c) in FIG. 2 ).
- the three-dimensional network structures 1a and 1b do not share an identical zinc(II) ion, and are independent of each other.
- the three-dimensional network structures 1a and 1b penetrate each other in a complex nested form so as to share an identical space to form a composite three-dimensional network structure.
- the polymer-metal complex 1 having the composite three-dimensional network structure has identical pores that are arranged in an ordered manner (see (d) in FIG. 2 ).
- the void ratio of the polymer-metal complex 1 is 50%.
- the diameter of the pore inscribed circle of the polymer-metal complex 1 is 5 to 8 ⁇ .
- Examples of the polymer-metal complex represented by the formula (6b) include [(ZnBr 2 ) 3 (TPT) 2 (PhNO 2 ) 5 (H 2 O)] n (polymer-metal complex 2) disclosed in JP-A-2008-214318 .
- the polymer-metal complex 2 has the same three-dimensional network structure as that of the polymer-metal complex 1, except that (ZnI 2 ) is replaced with (ZnBr 2 ).
- the pore shape, the pore size, and the void ratio of the polymer-metal complex 2 are almost the same as those of the polymer-metal complex 1.
- Examples of the polymer-metal complex represented by the formula (6c) include [(ZnI 2 ) 3 (TPT) 2 (TPH)(PhNO 2 ) 3.9 (MeOH) 1.8 ] n (polymer-metal complex 3) and [(ZnI 2 ) 3 (TPT) 2 (PER)(PhNO 2 ) 4 ] n (polymer-metal complex 4) disclosed in JP-A-2006-188560 .
- FIG. 3 illustrates the three-dimensional network structure of the polymer-metal complex 3.
- the three-dimensional network structure of the polymer-metal complex 3 includes three-dimensional network structures 1A and 1B.
- three-dimensional network structures 1A and 1A two iodide ions and the pyridyl groups of two TPT are coordinated to each zinc(II) ion to form a tetra-coordinated tetrahedral structure.
- the structures including the zinc(II) ion are three-dimensionally connected by TPT to form each three-dimensional network structure.
- the three-dimensional network structures 1A and 1B do not share an identical zinc(II) ion, and are independent of each other.
- the three-dimensional network structures 1A and 1B penetrate each other in a complex nested form so as to share an identical space to form a composite three-dimensional network structure.
- the triphenylene molecule (2) included in the polymer-metal complex 3 is firmly intercalated between the pi plane of tris(4-pyridyl)triazine (TPT (1a)) of the three-dimensional network structure 1A and the pi plane of tris(4-pyridyl)triazine (TPT (1b)) of the three-dimensional network structure 1B (see (b) in FIG. 3 ).
- the triphenylene molecule is stabilized by the pi-pi interaction between TPT (1a) and TPT (1b), and serves as part of the main framework of the polymer-metal complex 3.
- (b) is a side view of the area enclosed in (a).
- the polymer-metal complex 3 has two types of pores (pores A and B) that are arranged in the three-dimensional network structure in an ordered manner (see (c) in FIG. 3 ).
- the pores A and B are formed in an ordered manner in a laminate structure in which TPT and TPH are alternately stacked.
- the pore A has an approximately cylindrical shape, and is almost completely surrounded by the hydrogen atoms present at the side edge of the pi planes of a number of TPT and TPH that are stacked.
- the pore B is approximately in the shape of a triangular prism. Two sides among the three sides of the triangular prism are surrounded by the pi planes of TPT, and the remaining side is surrounded by the hydrogen atoms present at the side edge of the pi planes of a number of TPT and TPH that are stacked.
- the pores A and B have an elongated shape that meanders to some extent.
- the void ratio of the polymer-metal complex 3 is 28%.
- the diameter of the circle inscribed to the pore A of the polymer-metal complex 3 is 5 to 8 ⁇ .
- the diameter of the circle inscribed to the pore B of the polymer-metal complex 3 is 5 to 8 ⁇ .
- the polymer-metal complex 4 has the same framework structure as that of the polymer-metal complex 3, except that the perylene molecule is intercalated between two TPT instead of the triphenylene molecule.
- the pore shape, the pore size, and the void ratio of the polymer-metal complex 4 are almost the same as those of the polymer-metal complex 3.
- polymer-metal complex 5 examples include [(Co(NCS) 2 ) 3 (TPT) 4 (DCB) 25 (MeOH) 5 ] n (polymer-metal complex 5) disclosed in WO2011/062260 .
- FIG. 4 illustrates the three-dimensional network structure of the polymer-metal complex 5.
- the polymer-metal complex 5 has a (Co 6 (TPT) 4 ) structure that consists of six cobalt ions and four TPT as a structural unit.
- the structural unit has an octahedral shape, wherein a cobalt ion is situated at each vertex of the octahedron (see (b) in FIG. 4 ).
- the pyridyl groups of four TPT and two thiocyanate ions are coordinated to each cobalt(II) ion to form a hexa-coordinated octahedral structure.
- (b) is an enlarged view of the area enclosed in (a).
- the (Co 6 (TPT) 4 ) structure are three-dimensionally connected so as to share the cobalt ion situated at each vertex of the (Co 6 (TPT) 4 ) structure to form pores between the (Co 6 (TPT) 4 ) structures (see (c) in FIG. 4 ).
- the structural unit has a void therein.
- the void ratio of the polymer-metal complex 5 is 78%. This value is calculated using the total volume of the pores and the like.
- the diameter of the pore inscribed circle of the polymer-metal complex 5 is 10 to 18 ⁇ .
- the polymer-metal complex crystal including a guest compound according to one embodiment of the invention does not hinder introduction (incorporation) of the desired organic compound into the pores and the like, and be designed so that the guest compound (A) included in the pores and the like is replaced with the desired organic compound to form a polymer-metal complex crystal including an organic compound.
- At least one compound selected from the group consisting of an aliphatic hydrocarbon, an alicyclic hydrocarbon, an ether, an ester, an aromatic hydrocarbon, a halogenated hydrocarbon, and a nitrile is preferable as the guest compound (A) from the above point of view.
- the aliphatic hydrocarbon that may be used as the guest compound (A) is not particularly limited as long as the aliphatic hydrocarbon can enter the pores and the like.
- Examples of the aliphatic hydrocarbon that may be used as the guest compound (A) include a linear or branched saturated aliphatic hydrocarbon having 1 to 20 carbon atoms, such as methane, ethane, propane, butane, pentane, hexane, heptane, octane, decane, tetradecane, and octadecane; a linear or branched unsaturated aliphatic hydrocarbon having 2 to 20 carbon atoms that includes one or two or more double bonds or triple bonds in the molecule; and the like.
- the alicyclic hydrocarbon is not particularly limited as long as the alicyclic hydrocarbon can enter the pores and the like.
- the alicyclic hydrocarbon include a saturated alicyclic hydrocarbon having 3 to 20 carbon atoms, such as cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, cyclooctane, cyclononane, cyclodecane, cyclododecane, cycloundecane, and decalin; an unsaturated alicyclic hydrocarbon having 3 to 20 carbon atoms that is derived from these compounds, and has one or two or more double bonds or triple bonds in the molecule; and the like.
- the ether is not particularly limited as long as the ether can enter the pores and the like.
- examples of the ether include dimethyl ether, diethyl ether, dipropyl ether, dibutyl ether, t-butyl ether, dihexyl ether, methylethyl ether, tetrahydrofuran, 1,2-dimethoxyethane, 1,4-dioxane, and the like.
- the ester is not particularly limited as long as the ester can enter the pores and the like.
- Examples of the ester include ethyl formate, methyl acetate, ethyl acetate, propyl acetate, pentyl acetate, octyl acetate, ethyl lactate, ethyl propionate, methyl butanoate, ethyl butanoate, pentyl butanoate, pentyl valerate, and the like.
- the aromatic hydrocarbon is not particularly limited as long as the aromatic hydrocarbon can enter the pores and the like.
- Examples of the aromatic hydrocarbon include benzene, toluene, xylene, mesitylene, naphthalene, anthracene, phenanthrene, and the like.
- the halogenated hydrocarbon is not particularly limited as long as the halogenated hydrocarbon can enter the pores and the like.
- the halogenated hydrocarbon include the compounds mentioned above in connection with the aliphatic hydrocarbon, the alicyclic hydrocarbon, and the aromatic hydrocarbon, in which one or two or more carbon atoms are substituted with a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom.
- halogenated hydrocarbon examples include dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, trifluoromethane, chlorobenzene, bromobenzene, 1,2-dichlorobenzene, and the like.
- the nitrile is not particularly limited as long as the nitrile can enter the pores and the like.
- Examples of the nitrile include acetonitrile, benzonitrile, and the like.
- an alicyclic hydrocarbon having 3 to 20 carbon atoms and an aromatic hydrocarbon having 6 to 10 carbon atoms are preferable, an alicyclic hydrocarbon having 5 to 10 carbon atoms and an aromatic hydrocarbon having 6 to 10 carbon atoms are more preferable, cyclohexane and toluene are still more preferable, and cyclohexane is particularly preferable, since replacement with an organic compound can be easily achieved, and a high-quality crystal structure analysis sample can be easily prepared.
- the ratio of the amount of the guest compound (A) present in the polymer-metal complex to the total amount of the guest compound included in the pores and the like is 75 mol% or more, and preferably 90 mol% or more.
- the ratio of the amount of the guest compound (A) present in the polymer-metal complex to the total amount of the guest compound included in the pores and the like is less than 60 mol%, it may be difficult to easily prepare the target crystal structure analysis sample.
- the total occupancy ratio of the guest compound included in the pores and the voids of the polymer-metal complex is preferably 10% or more, more preferably 30% or more, and still more preferably 50% or more.
- the occupancy ratio is less than 10%, it may be impossible or very difficult to determine the structure of the guest compound by X-ray single crystal structure analysis, and the resulting structural data may have low chemical reliability.
- occupancy ratio refers to a value obtained by single crystal structure analysis, and represents the amount of guest compound actually present in the single crystal provided that the amount of guest compound in an ideal inclusion state is 100%.
- a method for producing a polymer-metal complex crystal including a guest compound includes immersing a polymer-metal complex crystal including a crystallization solvent in the guest compound (A) in a liquid state, or an inert solvent solution that includes the guest compound (A), the polymer-metal complex crystal including a crystallization solvent including a polymer-metal complex that includes a ligand having two or more coordinating moieties, and a metal ion that serves as a center metal, the polymer-metal complex having a three-dimensional network structure that is formed by the metal ion and the ligand that is coordinated to the metal ion, and having pores and the like that are three-dimensionally arranged in the three-dimensional network structure in an ordered manner, a crystallization solvent (excluding the guest compound (A), hereinafter the same) being included in the pores and the like.
- the production method includes (i) synthesizing a polymer-metal complex crystal in a crystallization solvent to obtain a polymer-metal complex crystal including a crystallization solvent, and (ii) immersing the polymer-metal complex crystal including the crystallization solvent in the guest compound (A) in a liquid state, or an inert solvent solution that includes the guest compound (A), to replace the crystallization solvent included in the pores and the like with the guest compound (A).
- the polymer-metal complex including a crystallization solvent used in connection with one embodiment of the invention may be synthesized using a known method that reacts a multidentate ligand and a metal ion-containing compound, for example.
- the polymer-metal complex including a crystallization solvent may be synthesized by adding a second solvent solution of a metal ion-containing compound to a first solvent solution of a multidentate ligand, and allowing the mixture to stand at 0 to 70°C for several hours to several days.
- the metal ion-containing compound is not particularly limited.
- Examples of the metal ion-containing compound include a compound represented by MX n . Note that M is a metal ion, X is a counter ion, and n is the valence of M.
- X include F - , Cl - , Br - , I - , SCN - , NO 3 - , ClO 4 - , BF 4 - , SbF 4 - , PF 6 - , AsF 6 - , CH 3 CO 2 - , and the like.
- such a compound examples include an aromatic hydrocarbon such as benzene, toluene, xylene, chlorobenzene, 1,2-dichlorobenzene, and nitrobenzene; an aliphatic hydrocarbon such as n-pentane, n-hexane, and n-heptane; an alicyclic hydrocarbon such as cyclopentane, cyclohexane, and cycloheptane; a nitrile such as acetonitrile and benzonitrile; a sulfoxide such as dimethyl sulfoxide (DMSO); an amide such as N,N-dimethylformamide and N-methylpyrrolidone; an ether such as diethyl ether, tetrahydrofuran, 1,2-dimethoxyethane, and 1,4-dioxane; an alcohol such as methanol, ethanol, and isopropyl alcohol; a ketone such as acet
- the first solvent and the second solvent be immiscible with each other (i.e., be separated into two layers).
- nitrobenzene, dichlorobenzene, nitrobenzene, or a mixed solvent thereof with methanol as the first solvent
- an alcohol such as methanol, ethanol, or isopropyl alcohol as the second solvent.
- the polymer-metal complexes 1 to 5 can be synthesized using the methods described in the above documents.
- the resulting polymer-metal complex has a three-dimensional network structure, and has pores and the like that are three-dimensionally arranged in the three-dimensional network structure in an ordered manner, and the crystallization solvent is included in the pores and the like.
- the target polymer-metal complex crystal including a guest compound can be obtained by immersing the polymer-metal complex crystal including a crystallization solvent in the guest compound (A) in a liquid state, or an inert solvent solution that includes the guest compound (A), to replace the crystallization solvent included in the pores and the like with the guest compound (A).
- Examples of the guest compound (A) include those mentioned above.
- the inert solvent is not particularly limited as long as the inert solvent is miscible with the guest compound (A), and inert to the polymer-metal complex (i.e., does not easily replace the crystallization solvent included in the pores and the like of the polymer-metal complex as compared with the guest compound (A)).
- the inert solvent include an alcohol such as methanol, ethanol, and isopropyl alcohol.
- the guest compound (A) When the guest compound (A) is liquid, the guest compound (A) may be used directly.
- the guest compound (A) in a liquid state, or the inert solvent solution that includes the guest compound (A) (hereinafter may be referred to as "solution of the guest compound (A)") is normally used in an amount of 1 to 100 mL, and preferably 5 to 30 mL, based on 100 mg of the polymer-metal complex crystal.
- the immersion temperature is not particularly limited, but is normally 0 to 70°C, preferably 10 to 70°C, and more preferably 20 to 60°C.
- the immersion time is determined so that 60% or more of the pores and the like are occupied by the guest compound (A).
- the immersion time is normally 6 hours or more, preferably 12 hours to 10 days, and more preferably 1 to 8 days.
- the immersion liquid i.e., the solution of the guest compound (A)
- the immersion liquid in amount equal to the amount of the supernatant liquid that has been removed, in order to promote replacement with the guest compound (A).
- Whether or not the guest compound (A) is included in the pores and the like may be determined by elemental analysis, X-ray crystal structure analysis, and the like.
- the polymer-metal complex crystal including a guest compound obtained as described above is designed so that the guest compound (A) included in the pores and the like is easily replaced with a trace amount of organic compound sample, the polymer-metal complex crystal including a guest compound is useful as a material for preparing a crystal structure analysis sample described later.
- the polymer-metal complex crystal including a guest compound obtained as described above makes it possible to efficiently introduce (incorporate) various other guest compounds without hindering guest replacement.
- the sample used for guest replacement need not be a crystalline solid, and may be a liquid, a gas, a noncrystalline solid, or the like.
- the amount of the guest compound necessary for inclusion may be 5 ⁇ g or less.
- Good X-ray single crystal structure analysis data can be obtained even when the amount of the guest compound is several tens of nanograms.
- X-ray single crystal structure analysis that utilizes the embodiments of the invention can accurately determine a steric structure including the absolute configuration of a molecule. It is also possible to determine the steric structure (absolute structure) of an unstable compound that easily undergoes thermal decomposition or solvolysis without heating the compound, or dissolving the compound in a solvent, a buffer, or the like.
- the polymer-metal complex crystal including a guest compound according to one embodiment of the invention be a single crystal having a cubic or cuboidal shape with a side length of 10 to 1000 ⁇ m, and preferably 60 to 200 ⁇ m.
- a high-quality crystal structure analysis sample can be easily obtained by utilizing the single crystal of the polymer-metal complex having such a shape.
- the single crystal of the polymer-metal complex including a guest compound according to one embodiment of the invention be designed so that the molecular structure of the resulting crystal structure analysis sample can be determined with a resolution of at least 1.5 ⁇ by applying MoKa radiation (wavelength: 0.71 ⁇ ) generated at a tube voltage of 24 kV and a tube current of 50 mA to the crystal structure analysis sample, and detecting diffracted X-rays using a CCD detector.
- a high-quality crystal structure analysis sample can be obtained by utilizing the single crystal of the polymer-metal complex having the above properties.
- a method for preparing a crystal structure analysis sample according to one embodiment of the invention prepares a crystal structure analysis sample in which the molecules of an organic compound for which the molecular structure is to be determined, are arranged in pores and the like of a polymer-metal complex crystal in an ordered manner, and includes immersing the polymer-metal complex crystal including a guest compound according to one embodiment of the invention in a solvent solution that includes the organic compound.
- organic compound ( ⁇ ) The organic compound for which the molecular structure is to be determined (hereinafter may be referred to as "organic compound ( ⁇ )”) is not particularly limited as long as the organic compound has a size that allows the organic compound to enter the pores and the like of the polymer-metal complex.
- the organic compound ( ⁇ ) is a low-molecular-weight compound, the molecular weight of the organic compound ( ⁇ ) is normally 20 to 3000, and preferably 100 to 500.
- the organic compound ( ⁇ ) is a chain-like polymer compound (e.g., polyethylene) that includes a repeating unit
- the molecular weight of the organic compound ( ⁇ ) is normally 10 3 to 10 6 , and preferably 10 4 to 10 5 .
- the organic compound ( ⁇ ) may be either solid or liquid at about room temperature (about 25°C).
- the organic compound ( ⁇ ) it is preferable to roughly determine the size of the organic compound ( ⁇ ) in advance by nuclear magnetic resonance spectroscopy, mass spectrometry, elemental analysis, or the like, and appropriately select the polymer-metal complex crystal including a guest compound corresponding to the size of the organic compound ( ⁇ ).
- the organic compound ( ⁇ ) is impurities included in a synthetic compound (e.g., a compound derived from a natural product, agricultural chemical, medicine, or synthetic polymer), it is preferable to increase the purity of the organic compound ( ⁇ ) using a known purification method such as liquid chromatography, and then prepare the crystal structure analysis sample using the method according to one embodiment of the invention.
- a synthetic compound e.g., a compound derived from a natural product, agricultural chemical, medicine, or synthetic polymer
- the eluant that includes the target product may be used directly as the solvent solution of the organic compound described later.
- the method for preparing a crystal structure analysis sample can prepare the crystal structure analysis sample without requiring a large amount of the organic compound ( ⁇ ), and is useful when only a trace amount of the organic compound ( ⁇ ) is available (e.g., when the organic compound ( ⁇ ) is impurities included in a compound derived from a natural product, an agricultural chemical, or a medicine).
- the organic compound ( ⁇ ) may be either solid or liquid at room temperature (20°C).
- the amount of the organic compound ( ⁇ ) included in the solvent solution is not particularly limited, and may be 100 ⁇ g or less.
- the lower limit of the amount of the organic compound ( ⁇ ) included in the solvent solution is normally 0.5 ⁇ g or more.
- the method for preparing a crystal structure analysis sample according to one embodiment of the invention include immersing the single crystal of the polymer-metal complex including a guest compound in the solvent solution that includes the organic compound in an amount of 100 ⁇ g or less so that a value A calculated by the following expression (2) is 100 or less, preferably 0.1 to 30, and more preferably 1 to 5.
- A b a
- b is the amount of the organic compound included in the solvent solution
- a is the amount of a substance having a specific gravity of 1 that is required to fill all of the pores and the like of the polymer-metal complex crystal with the substance having a specific gravity of 1.
- the organic compound ( ⁇ ) is sufficiently introduced into the pores and the like of the single crystal of the polymer-metal complex, and a high-quality crystal structure analysis sample is easily obtained.
- the target crystal structure analysis sample can be obtained even when the value A is large.
- a further improvement in effects may not be achieved, and the organic compound ( ⁇ ) may be wasted.
- the method according to one embodiment of the invention is useful when preparing a crystal structure analysis sample for determining the structure of an organic compound that is available in an only trace amount (e.g., impurities included in a compound derived from a natural product, an agricultural chemical, or a medicine).
- organic compound ( ⁇ ) need not necessarily be included in all of the pores and the likes of the polymer-metal complex. It is possible to prepare a high-quality crystal structure analysis sample even when the value A is smaller than 1.
- the concentration of the organic compound ( ⁇ ) in the solvent solution is not particularly limited.
- the concentration of the organic compound ( ⁇ ) in the solvent solution is normally 0.001 to 50 ⁇ g/ ⁇ L, preferably 0.01 to 5 ⁇ g/ ⁇ L, and more preferably 0.1 to 1 ⁇ g/ ⁇ L, from the viewpoint of efficiently preparing a high-quality crystal structure analysis sample.
- the solvent used to prepare the solvent solution is not particularly limited as long as the solvent does not dissolve the crystal of the polymer-metal complex, and dissolves the organic compound ( ⁇ ), and the solvent solution of the organic compound ( ⁇ ) can be concentrated by volatilizing the solvent from the solvent solution of the organic compound ( ⁇ ).
- the solvent include an aromatic hydrocarbon such as benzene, toluene, xylene, chlorobenzene, and 1,2-dichlorobenzene; an aliphatic hydrocarbon such as n-pentane, n-hexane, and n-heptane; an alicyclic hydrocarbon such as cyclopentane, cyclohexane, and cycloheptane; a nitrile such as acetonitrile and benzonitrile; a sulfoxide such as dimethyl sulfoxide; an amide such as N,N-dimethylformamide and N-methylpyrrolidone; an ether such as diethyl ether, tetrahydrofuran, 1,2-dimethoxyethane, and 1,4-dioxane; an alcohol such as methanol, ethanol, and isopropyl alcohol; a ketone such as acetone, methyl ethyl ket
- the polymer-metal complex crystal including a guest compound according to one embodiment of the invention is immersed in the solvent solution that includes the organic compound ( ⁇ ).
- the number of single crystals of the polymer-metal complex including a guest compound to be immersed in the solvent solution is not particularly limited as long as the requirement relating to the value A is satisfied.
- the target crystal structure analysis sample can be obtained by immersing one single crystal.
- the amount of the organic compound ( ⁇ ) is large, two or more single crystals of an identical polymer-metal complex including a guest compound may be immersed in the solvent solution, or single crystals of different polymer-metal complexes including a guest compound may be immersed in the solvent solution at the same time.
- the solvent is volatilized under moderate conditions after immersing the single crystal of the polymer-metal complex including a guest compound in the solvent solution to concentrate the solvent solution. This makes it possible to efficiently introduce a trace amount of the organic compound ( ⁇ ) into the pores and the like of the single crystal.
- the immersion conditions are not particularly limited.
- the temperature of the solvent is preferably 0 to 180°C, more preferably 0 to 80°C, and still more preferably 20 to 60°C.
- the immersion time is normally 6 hours or more, preferably 12 to 168 hours, and more preferably 24 to 78 hours.
- the volatilization rate of the solvent is preferably 0.1 to 1000 ⁇ L/24 hours, more preferably 1 to 100 ⁇ L/24 hours, and still more preferably 5 to 50 ⁇ L/24 hours.
- volatilization rate of the solvent is to high, it may be difficult to obtain a high-quality crystal structure analysis sample. If the volatilization rate of the solvent is to low, the work efficiency may deteriorate.
- the temperature employed when volatilizing the solvent is determined taking account of the boiling point of the organic solvent, but is normally 0 to 180°C, preferably 0 to 120°C, and more preferably 15 to 60°C.
- the operation that volatilizes the solvent after immersing the polymer-metal complex crystal including a guest compound in the solvent solution that includes the organic compound ( ⁇ ) to concentrate the solvent solution may be performed under normal pressure, or may be performed under reduced pressure, or may be performed under pressure.
- the pressure employed when performing the operation that volatilizes the solvent to concentrate the solvent solution is normally 1 to 1 ⁇ 10 6 Pa, and preferably to 1 ⁇ 10 to 1 ⁇ 10 6 Pa.
- the volatilization rate of the solvent can be appropriately adjusted by adjusting the temperature and the pressure employed when performing the operation that concentrates the solvent solution.
- the method for preparing a crystal structure analysis sample may include a step (I) that separates a mixture that includes the organic compound ( ⁇ ) by liquid chromatography to obtain a solvent solution of the organic compound ( ⁇ ), and a step (II) that immerses the single crystal of the polymer-metal complex including a guest compound in the solvent solution of the organic compound ( ⁇ ) that has been obtained in the step (I), and volatilizes the solvent under moderate conditions to concentrate the solvent solution.
- a mixture that includes the organic compound ( ⁇ ) is separated using a liquid chromatography device to obtain a solvent solution of the organic compound ( ⁇ ) (i.e., a solution that includes the organic compound ( ⁇ ) as an organic compound other than the solvent), the single crystal of the polymer-metal complex including a guest compound according to one embodiment of the invention is immersed in the solvent solution of the organic compound ( ⁇ ) (fraction A), and the solvent is volatilized under moderate conditions to concentrate the solvent solution to obtain a crystal structure analysis sample.
- a solvent solution of the organic compound ( ⁇ ) i.e., a solution that includes the organic compound ( ⁇ ) as an organic compound other than the solvent
- the single crystal of the polymer-metal complex including a guest compound according to one embodiment of the invention is immersed in the solvent solution of the organic compound ( ⁇ ) (fraction A), and the solvent is volatilized under moderate conditions to concentrate the solvent solution to obtain a crystal structure analysis sample.
- the solvent of the solvent solution may be replaced with another solvent, and the crystal of the polymer complex may be immersed in the resulting solution.
- a crystal structure analysis sample can be prepared by separating a mixture of a plurality of compounds having a similar structure by liquid chromatography, and immersing the crystal of the polymer-metal complex in each of the solvent solutions respectively including the separated compounds.
- This method is useful when separating a mixture of compounds having a similar structure for which it is difficult to determine the structure of each compound based only on the measurement data (e.g., NMR spectrum), and determining the molecular structure of each compound.
- the method for preparing a crystal structure analysis sample according to one embodiment of the invention can also be applied the case where the organic compound ( ⁇ ) is a substance that is liquid at about room temperature (about 25°C).
- the single crystal of the polymer-metal complex including a guest compound according to one embodiment of the invention is immersed in the solvent solution of a liquid organic compound ( ⁇ ), and the solvent is volatilized under moderate conditions to concentrate the solvent solution to prepare a crystal structure analysis sample.
- a trace amount of a liquid organic compound ( ⁇ ) may be dropped onto the single crystal of the polymer-metal complex including a guest compound according to one embodiment of the invention using a dropper or the like, and the single crystal may be allowed to stand at room temperature (25°C) for several hours to several days to prepare a crystal structure analysis sample.
- the organic compound ( ⁇ ) is volatile at about room temperature (25°C)
- the molecular structure of the resulting crystal structure analysis sample can be determined with a resolution of at least 1.5 ⁇ by applying MoKa radiation (wavelength: 0.71 ⁇ ) generated at a tube voltage of 24 kV and a tube current of 50 mA to the crystal structure analysis sample, and detecting diffracted X-rays using a CCD detector.
- a crystal structure analysis sample obtained using the method according to one embodiment of the invention has a configuration in which the molecules of the organic compound ( ⁇ ) that has replaced the guest compound (A) are arranged in the pores and the like of the single crystal of the polymer-metal complex in an ordered manner.
- the organic compound ( ⁇ ) need not necessarily be included in all of the pores and the like of the single crystal of the polymer-metal complex as long as the structure of the organic compound ( ⁇ ) can be determined.
- the solvent used for the solvent solution of the organic compound ( ⁇ ) may be included in some of the pores and the like of the single crystal of the polymer-metal complex.
- the occupancy ratio of the molecules of the organic compound in the crystal structure analysis sample obtained using the method according to one embodiment of the invention be 10% or more.
- the occupancy ratio of the molecules of the organic compound refers to a value obtained by single crystal structure analysis, and represents the amount of guest molecules actually present in the single crystal provided that the amount of guest molecules (organic compound ( ⁇ )) in an ideal inclusion state is 100%.
- the preparation device A or the preparation device B illustrated in FIG. 5 may be used, for example.
- FIG. 5 (a) is a side view illustrating the preparation device A, and (b) is a top view illustrating the preparation device A.
- Reference sign 11 indicates a cap
- reference sign 12 indicates an opening that allow gaseous molecules to pass through
- reference sign 13 indicates a container main body
- reference sign 14 indicates a solvent solution of the organic compound ( ⁇ )
- reference sign 15 indicates a single crystal of a polymer-metal complex.
- the cap (11) is not particularly limited as long as the container can be closed air-tightly.
- a cap made of rubber e.g., septum
- the opening (12) may be formed by inserting a degassing hollow needle into the cap (11), for example.
- a container made of glass e.g., test tube or pressure-resistant glass bottle
- the bottom of the container main body (13) may be flat. Note that it is preferable that the bottom of the container main body (13) have a pointed shape (see (a) in FIG. 5 ) since the crystal can be easily placed and removed (i.e., excellent operability is achieved).
- the container main body (13) When a transparent container is used as the container main body (13), it is possible to easily observe the volatilization state of the solvent and a change in color of the crystal (i.e., the color of the crystal changes when the guest molecules are introduced into the pores and the voids of the polymer-metal complex) from the outside.
- a change in color of the crystal i.e., the color of the crystal changes when the guest molecules are introduced into the pores and the voids of the polymer-metal complex
- the solvent included in the solvent solution (14) of the organic compound ( ⁇ ) gradually volatilizes through the thin opening (12) (degassing hollow needle), and is completely removed from the organic compound ( ⁇ ).
- the crystal structure analysis sample is removed from the container main body (vial) (13), and crystal structure analysis is performed using the crystal structure analysis sample.
- (c) is a side view illustrating the preparation device B
- (d) is a top view illustrating the preparation device B.
- the preparation device B includes an airtight container that includes a cap (11), a container main body (13), and an opening (12) that allow gaseous molecules to pass through, and a crystal support (16) that is secured on the cap, and is configured so that a single crystal (15) of a polymer-metal complex that includes a ligand having two or more coordinating moieties, and a metal ion that serves as a center metal, and has a three-dimensional network structure can be secured on the front end of the crystal support (16), and the front end of the crystal support (16) is situated downward inside the container when the container is closed.
- the preparation device B illustrated in FIG. 5 is configured so that the single crystal (15) of the polymer-metal complex is secured on the front end of the crystal support (16) using a cryoloop (not illustrated in FIG. 5 ).
- the preparation device B be configured so that it is possible to introduce the organic compound ( ⁇ ) into the pores and the voids of the polymer-metal complex to obtain a crystal structure analysis sample, and transfer the crystal structure analysis sample directly to a crystal structure analyzer such as an X-ray crystal structure analyzer to perform measurement.
- a crystal structure analyzer such as an X-ray crystal structure analyzer
- a method for determining the molecular structure of an organic compound according to one embodiment of the invention includes analyzing the crystal structure of a crystal structure analysis sample obtained using the method for preparing a crystal structure analysis sample according to one embodiment of the invention to determine the molecular structure of the organic compound included in the pores and the voids of the crystal structure analysis sample.
- the method for determining the molecular structure of an organic compound according to one embodiment of the invention may utilize X-ray diffraction or neutron diffraction.
- a known method may be used, except that the crystal structure analysis sample obtained using the method for preparing a crystal structure analysis sample according to one embodiment of the invention is mounted instead of a known single crystal.
- the method for determining the molecular structure of an organic compound according to one aspect of the invention can efficiently analyze the crystal structure of an organic compound, and determine the molecular structure of the organic compound even when the amount of the organic compound is very small.
- the method for determining the molecular structure of an organic compound according to one aspect of the invention can determine the molecular structure of an organic compound that is liquid at room temperature by utilizing the crystal structure analysis sample that includes the organic compound.
- the organic compound used to prepare the sample may be a gas, a liquid, or a solid.
- the organic compound can be introduced into the single crystal of the polymer-metal complex as long as the organic compound can be dissolved in an organic solvent.
- the amount of the organic compound required for one piece of the single crystal of the polymer-metal complex may be 5 ⁇ g or less. A single crystal structure can be obtained even when the amount of the organic compound is 50 ng.
- X-ray single crystal structure analysis was performed using an APEX II/CCD diffractometer (manufactured by Bruker, radiation source: Mo-K ⁇ radiation (wavelength: 0.71 ⁇ ), output: 50 mA, 24 kV).
- Elemental analysis was performed using an analyzer "MT-6" (manufactured by YANACO).
- Example 1 Synthesis of polymer-metal complex crystal including cyclohexane
- Step 1 Synthesis of polymer-metal complex crystal including crystalline solvent (nitrobenzene)
- TPT 2,4,6-tris(4-pyridyl)-1,3,5-triazine
- the resulting white powdery sample was identified by elemental analysis and thermogravimetry-mass spectrometry (TG-MS), and found to be [(ZnI 2 ) 3 (TPT) 2 (PhNO 2 ) 5.5 ] n (polymer-metal complex 1).
- Step 2 Synthesis of polymer-metal complex crystal including guest molecule (cyclo hexane)
- the polymer-metal complex 1 (polymer-metal complex crystal including nitrobenzene) obtained in the step 1 was immersed in cyclohexane in a ratio of 100 mg/10 mL. The mixture was heated to 45°C using an incubator, and allowed to stand for 1 week. The supernatant liquid (cyclohexane) was exchanged by decantation every other day during this period.
- the single crystal was removed, and identified by elemental analysis and crystal structure analysis. It was found that the single crystal was [(ZnI 2 ) 3 (TPT) 2 (cyclohexane) 4 ].
- Table 1 shows the crystallographic data.
- FIG. 6 shows a micrograph of the single crystal.
- FIGS. 7 and 8 show the crystal structure of the resulting polymer-metal complex crystal including cyclohexane.
- Example 2 Synthesis of polymer-metal complex crystal including ethyl acetate
- the ligand solution was put in a test tube (diameter: 15 mm, height: 12 cm), and the metal ion-containing solution was slowly added to the test tube so as to form a layer on the ligand solution.
- the solutions were allowed to stand at 15 to 25°C for 7 days to obtain a polymer-metal complex crystal.
- the resulting crystal was identified by elemental analysis, thermogravimetry-mass spectrometry, and X-ray single crystal structure analysis in the same manner as in Example 1, and found to be [(ZnI 2 ) 3 (TPT) 2 (PhNO 2 ) 5.5 ] n .
- TPT 6.3 mg of TPT was dissolved in 5 mL of a 1,2-dichlorobenzene/methanol (volume ratio: 4:1) mixture in a test tube.
- the resulting polymer-metal complex was subjected to elemental analysis and X-ray single crystal structural analysis, and found to be (TPT) 4 ⁇ Co(SCN) 2 ⁇ 3 (Cl 2 C 6 H 4 ) 25 (MeOH) 5 having the same structure as that illustrated in FIG. 4 .
- the polymer-metal complex included twenty-five 1,2-dichlorobenzene molecules and five methanol molecules per regular octahedral structural unit.
- a micro vial with a septum cap was charged with 50 ⁇ L of ethyl acetate, and one piece (size: 150 ⁇ 150 ⁇ 100 ⁇ m, theoretical amount of a substance having a specific gravity of 1 required to fill the pores therewith: 1.13 ⁇ g) of the single crystal of the polymer-metal complex including ethyl acetate ([(ZnI 2 ) 3 (TPT) 2 (AcOEt) 3 ]) obtained in Example 2 was immersed in ethyl acetate contained in the micro vial.
- 2-Methyl-1,4-naphthoquinone was dissolved in dichloromethane at a concentration of 1 ⁇ g/1 ⁇ L, and 5 ⁇ L of the resulting sample solution (including 2-methyl-1,4-naphthoquinone in an amount of 5 ⁇ g) was added to the micro vial.
- the value A in Example 10 was 4.4.
- a pinhole was formed in the septum using a syringe needle (hole diameter: 0.8 mm), and the micro vial was allowed to stand in a temperature-controlled room at 45°C for 2 days.
- the organic solvent ethyl acetate and dichloromethane contained in the micro vial volatilized at a volatilization rate of about 48 ⁇ L/24 hours under the above conditions, and the solution was concentrated.
- the single crystal was then removed, mounted on an X-ray crystal structure analyzer, and subjected to crystal structure analysis.
- Tables 2 shows the crystallographic data, and FIGS. 9 and 10 show the crystal structure.
- Example 11 Synthesis of polymer-metal complex crystal including 4-cyano-4' -pentylbiphenyl
- a micro vial with a septum cap was charged with 50 ⁇ L of heptane, and one piece (size: 200 ⁇ 60 ⁇ 50 ⁇ m, theoretical amount of a substance having a specific gravity of 1 required to fill the pores therewith: 0.30 ⁇ g) of the single crystal of the polymer-metal complex including heptane ([(ZnI 2 ) 3 (TPT) 2 (nitrobenzene)(heptane) 2.5 ]) obtained in Example 2 was immersed in heptane contained in the micro vial.
- heptane [(ZnI 2 ) 3 (TPT) 2 (nitrobenzene)(heptane) 2.5 ]
- a pinhole was formed in the septum using a syringe needle (hole diameter: 0.8 mm), and the micro vial was allowed to stand in a temperature-controlled room at 45°C for 2 days.
- the organic solvent (heptane and dichloromethane) contained in the micro vial volatilized at a volatilization rate of about 48 ⁇ L/24 hours under the above conditions, and the solution was concentrated.
- the single crystal was then removed, mounted on an X-ray crystal structure analyzer, and subjected to crystal structure analysis.
- Tables 3 shows the crystallographic data, and FIGS. 11 and 12 show the crystal structure.
- TABLE 3 Crystal system Monoclinic Space group C2/c a ( ⁇ ) 35.562 b ( ⁇ ) 14.7759 c ( ⁇ ) 31.573 ⁇ (°) 90 ⁇ (°) 102.981 ⁇ (°) 90 Z 8 R1 7.54
- Example 12 Synthesis of polymer-metal complex crystal including 1,4-dimethyl-7-isopropylazulene
- a micro vial with a septum cap (see (a) in FIG. 5 ) was charged with 50 ⁇ L of cyclohexane, and one piece (size: 100 ⁇ 100 ⁇ 60 ⁇ m, theoretical amount of a substance having a specific gravity of 1 required to fill the pores therewith: 0.3 ⁇ g) of the single crystal of the polymer-metal complex including cyclohexane obtained in Example 8 was immersed in cyclohexane contained in the micro vial.
- 1,4-Dimethyl-7-isopropylazulene was dissolved in dichloromethane at a concentration of 1 ⁇ g/1 ⁇ L, and 5 ⁇ L of the resulting sample solution (including 1,4-dimethyl-7-isopropylazulene in an amount of 5 ⁇ g) was added to the micro vial.
- the value A in Example 12 was 16.7.
- a pinhole was formed in the septum using a syringe needle (hole diameter: 0.8 mm), and the micro vial was allowed to stand in a temperature-controlled room at 45°C for 2 days.
- the organic solvent (cyclohexane and dichloromethane) contained in the micro vial volatilized at a volatilization rate of about 48 ⁇ L/24 hours under the above conditions, and the solution was concentrated.
- the single crystal was then removed, mounted on an X-ray crystal structure analyzer, and subjected to crystal structure analysis.
- the diffraction pattern illustrated in FIG. 13 was obtained at an exposure time of 30 seconds, and the resolution was 0.8 ⁇ or more.
- Tables 4 shows the crystallographic data, and FIGS. 14 and 15 show the crystal structure. Note that the occupancy ratio of 1,4-dimethyl-7-isopropylazulene was 73%.
- TABLE 4 Crystal system Monoclinic Space group C2/c a ( ⁇ ) 34.942 b ( ⁇ ) 14.8462 c ( ⁇ ) 30.976 ⁇ (°) 90 ⁇ (°) 102.149 ⁇ (°) 90 Z 8 R1 10.6
- Example 13 Synthesis of polymer-metal complex crystal including (3S,3aS,5aS,9bS)-3a,5,5a,9b-tetrahydro-3,5a,9-trimethylnaphtho[1,2-b]furan-2,8(3H,4H)-dione
- a micro vial with a septum cap (see (a) in FIG. 5 ) was charged with 50 ⁇ L of cyclohexane, and one piece (size: 350 ⁇ 70 ⁇ 50 ⁇ m, theoretical amount of a substance having a specific gravity of 1 required to fill the pores therewith: 0.61 ⁇ g) of the single crystal obtained in Example 8 was immersed in cyclohexane contained in the micro vial.
- a pinhole was formed in the septum using a syringe needle (hole diameter: 0.8 mm), and the micro vial was allowed to stand in a temperature-controlled room at 45°C for 2 days.
- the organic solvent (cyclohexane and dichloromethane) contained in the micro vial volatilized at a volatilization rate of about 48 ⁇ L/24 hours under the above conditions, and the solution was concentrated.
- the single crystal was then removed, mounted on an X-ray crystal structure analyzer, and subjected to crystal structure analysis.
- Tables 5 shows the crystallographic data, and FIGS. 16 and 17 show the crystal structure. Note that the occupancy ratio of (3S,3aS,5aS,9bS)-3a,5,5a,9b-tetrahydro-3,5a,9-trimethylnaphtho[1,2-b]furan-2,8(3H,4H)-dione was 100%.
- TABLE 5 Crystal system Monoclinic Space group P2 1 a ( ⁇ ) 32.866 b ( ⁇ ) 14.853 c ( ⁇ ) 34.85 ⁇ (°) 90 ⁇ (°) 105.848 ⁇ (°) 90 Z 2 R1 8.27
- Example 14 Synthesis of polymer-metal complex crystal including 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one
- a micro vial with a septum cap (see (a) in FIG. 5 ) was charged with 50 ⁇ L of cyclohexane, and one piece (size: 130 ⁇ 110 ⁇ 80 ⁇ m, theoretical amount of a substance having a specific gravity of 1 required to fill the pores therewith: 0.57 ⁇ g) of the single crystal obtained in Example 8 was immersed in cyclohexane contained in the micro vial.
- a pinhole was formed in the septum using a syringe needle (hole diameter: 0.8 mm), and the micro vial was allowed to stand in a temperature-controlled room at 45°C for 2 days.
- the organic solvent (cyclohexane and dichloromethane) contained in the micro vial volatilized at a volatilization rate of about 48 ⁇ L/24 hours under the above conditions, and the solution was concentrated.
- the single crystal was then removed, mounted on an X-ray crystal structure analyzer, and subjected to crystal structure analysis.
- Tables 6 shows the crystallographic data, and FIGS. 18 and 19 show the crystal structure. Note that the occupancy ratio of 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one was 53%. TABLE 6 Crystal system Monoclinic Space group C2/c a ( ⁇ ) 34.562 b ( ⁇ ) 14.95 c ( ⁇ ) 30.348 ⁇ (°) 90 ⁇ (°) 100.119 ⁇ (°) 90 Z 8 R1 13.13
- Example 15 Synthesis of polymer-metal complex crystal including 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one
- a micro vial with a septum cap (see (a) in FIG. 5 ) was charged with 50 ⁇ L of cyclohexane, and one piece (size: 300 ⁇ 100 ⁇ 100 ⁇ m, theoretical amount of a substance having a specific gravity of 1 required to fill the pores therewith: 1.5 ⁇ g) of the single crystal obtained in Example 8 was immersed in cyclohexane contained in the micro vial.
- a pinhole was formed in the septum using a syringe needle (hole diameter: 0.8 mm), and the micro vial was allowed to stand in a temperature-controlled room at 45°C for 2 days.
- the organic solvent (cyclohexane and dichloromethane) contained in the micro vial volatilized at a volatilization rate of about 48 ⁇ L/24 hours under the above conditions, and the solution was concentrated.
- the single crystal was then removed, mounted on an X-ray crystal structure analyzer, and subjected to crystal structure analysis.
- Tables 7 shows the crystallographic data, and FIGS. 20 and 21 show the crystal structure. Note that the occupancy ratio of 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one was 80%.
- TABLE 7 Crystal system Monoclinic Space group C2/c a ( ⁇ ) 34.103 b ( ⁇ ) 14.767 c ( ⁇ ) 30.7 ⁇ (°) 90 ⁇ (°) 99.802 ⁇ (°) 90 Z 8 R1 9.52
- Example 9 100 mg of the single crystal of the cobalt complex obtained in Example 9 was immersed in 10 mL of toluene for 2 days to saturate the pores of the single crystal with toluene.
- a micro vial with a septum cap (see (a) in FIG. 5 ) was charged with 50 ⁇ L of toluene, and one piece (size: 320 ⁇ 300 ⁇ 280 ⁇ m, theoretical amount of a substance having a specific gravity of 1 required to fill the pores therewith: 21.0 ⁇ g) of the single crystal that had been immersed in toluene, was immersed in toluene contained in the micro vial.
- the value A in Example 16 was 0.31.
- 2,2'-Bithiophene was dissolved in toluene at a concentration of 1 ⁇ g/1 ⁇ L, and 5 ⁇ L of the resulting sample solution (including 2,2'-bithiophene in an amount of 50 ⁇ g) was added to the micro vial.
- the single crystal was removed, mounted on an X-ray crystal structure analyzer, and subjected to crystal structure analysis.
- Tables 8 shows the crystallographic data, and FIGS. 22 and 23 show the crystal structure. Note that the occupancy ratio of 2,2'-bithiophene was 100%.
- TABLE 8 Crystal system Tetragonal Space group P42/mnm a ( ⁇ ) 26.58 b ( ⁇ ) 26.58 c ( ⁇ ) 36.273 ⁇ (°) 90 ⁇ (°) 90 ⁇ (°) 90 Z 16 R1 11.08
- the resulting polymer complex was dissolved in hydrochloric acid, extracted with deuterated chloroform, and subjected to NMR measurement. As a result, only nitrobenzene and cyclohexane were observed in a ratio (cyclohexane:nitrobenzene) of 39:61.
- a micro vial with a septum cap was charged with 50 ⁇ L of cyclohexane, and one piece (size: 150 ⁇ 130 ⁇ 120 ⁇ m, theoretical amount of a substance having a specific gravity of 1 required to fill the pores therewith: 1.17 ⁇ g) of the resulting single crystal was immersed in cyclohexane contained in the micro vial.
- a pinhole was formed in the septum using a syringe needle (hole diameter: 0.8 mm), and the micro vial was allowed to stand in a temperature-controlled room at 45°C for 2 days.
- the organic solvent (cyclohexane and dichloromethane) contained in the micro vial volatilized at a volatilization rate of about 48 ⁇ L/24 hours under the above conditions, and the solution was concentrated.
- the single crystal was then removed, mounted on an X-ray crystal structure analyzer, and subjected to crystal structure analysis.
- Tables 9 shows the crystallographic data
- FIGS. 24 and 25 show the crystal structure.
- a micro vial with a septum cap was charged with 50 ⁇ L of cyclohexane, and one piece of the single crystal was immersed in cyclohexane contained in the micro vial.
- a pinhole was formed in the septum using a syringe needle (hole diameter: 0.8 mm), and the micro vial was allowed to stand in a temperature-controlled room at 45°C for 2 days.
- the organic solvent (cyclohexane and dichloromethane) contained in the micro vial volatilized at a volatilization rate of about 48 ⁇ L/24 hours under the above conditions, and the solution was concentrated.
- the single crystal was then removed, mounted on an X-ray crystal structure analyzer, and subjected to crystal structure analysis.
- 100 mg of the single crystal of the polymer-metal complex obtained in the step 1 of Example 1 was immersed in 10 mL of cyclohexanone at 25°C for 7 days to saturate the pores of the single crystal with cyclohexanone to obtain a polymer-metal complex crystal including cyclohexanone.
- the polymer-metal complex crystal was placed on a glass plate, and one drop (about 100 ⁇ g) of isoprene (or cyclohexanone) was dropped onto the complex using a dropper.
- the polymer-metal complex crystal was transferred to a micro vial with a septum cap (not illustrated in FIG. 26 ), and the micro vial was placed in a temperature-controlled room at 25°C for 2 days to obtain a crystal structure analysis sample.
- the resulting sample was removed, mounted on an X-ray crystal structure analyzer, and subjected to crystal structure analysis.
- FIG. 27 is an enlarged view showing the crystal structure of the polymer-metal complex including isoprene.
- Example 9 100 mg of the single crystal of the cobalt complex obtained in Example 9 was immersed in 10 mL of toluene at 25°C for 7 days to saturate the pores of the single crystal with toluene to obtain a polymer-metal complex crystal including toluene.
- the polymer-metal complex crystal was placed on a glass plate, and one drop (about 100 ⁇ g) of cyclohexanone was dropped onto the complex using a dropper.
- the polymer-metal complex crystal was allowed to stand in a temperature-controlled room at 25°C for 2 days to obtain a crystal structure analysis sample.
- the resulting sample was removed, mounted on an X-ray crystal structure analyzer, and subjected to crystal structure analysis.
- FIG. 28 is an enlarged view showing the crystal structure of the polymer-metal complex including cyclohexanone.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Metallurgy (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19188421.2A EP3591103A1 (en) | 2012-09-07 | 2013-03-07 | Guest-compound-enveloping polymer-metal-complex crystal, method for producing same, method for preparing crystal structure analysis sample, and method for determining molecular structure of organic compound |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012197911 | 2012-09-07 | ||
JP2012270199 | 2012-12-11 | ||
PCT/JP2013/056370 WO2014038220A1 (ja) | 2012-09-07 | 2013-03-07 | ゲスト化合物内包高分子金属錯体結晶、その製造方法、結晶構造解析用試料の作製方法、及び有機化合物の分子構造決定方法 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19188421.2A Division-Into EP3591103A1 (en) | 2012-09-07 | 2013-03-07 | Guest-compound-enveloping polymer-metal-complex crystal, method for producing same, method for preparing crystal structure analysis sample, and method for determining molecular structure of organic compound |
EP19188421.2A Division EP3591103A1 (en) | 2012-09-07 | 2013-03-07 | Guest-compound-enveloping polymer-metal-complex crystal, method for producing same, method for preparing crystal structure analysis sample, and method for determining molecular structure of organic compound |
Publications (3)
Publication Number | Publication Date |
---|---|
EP2894242A1 EP2894242A1 (en) | 2015-07-15 |
EP2894242A4 EP2894242A4 (en) | 2016-06-22 |
EP2894242B1 true EP2894242B1 (en) | 2020-01-15 |
Family
ID=50236849
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13835833.8A Active EP2894242B1 (en) | 2012-09-07 | 2013-03-07 | Guest-compound-enveloping polymer-metal-complex crystal, method for producing same, method for preparing crystal structure analysis sample, and method for determining molecular structure of organic compound |
EP19188421.2A Pending EP3591103A1 (en) | 2012-09-07 | 2013-03-07 | Guest-compound-enveloping polymer-metal-complex crystal, method for producing same, method for preparing crystal structure analysis sample, and method for determining molecular structure of organic compound |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19188421.2A Pending EP3591103A1 (en) | 2012-09-07 | 2013-03-07 | Guest-compound-enveloping polymer-metal-complex crystal, method for producing same, method for preparing crystal structure analysis sample, and method for determining molecular structure of organic compound |
Country Status (5)
Country | Link |
---|---|
US (2) | US10190952B2 (ja) |
EP (2) | EP2894242B1 (ja) |
JP (1) | JP5969616B2 (ja) |
TW (2) | TWI501990B (ja) |
WO (2) | WO2014038221A1 (ja) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014038221A1 (ja) * | 2012-09-07 | 2014-03-13 | 独立行政法人 科学技術振興機構 | 結晶構造解析用試料の作製方法、有機化合物の分子構造決定方法、及び結晶構造解析用試料の作製装置 |
JP2017083172A (ja) * | 2014-03-10 | 2017-05-18 | 国立研究開発法人科学技術振興機構 | 結晶構造解析用試料の作製方法、及び官能基を有する有機化合物の分子構造決定方法 |
WO2016017770A1 (ja) * | 2014-07-31 | 2016-02-04 | 国立研究開発法人 科学技術振興機構 | 回折データの解析方法、コンピュータプログラム及び記録媒体 |
JP6607594B2 (ja) * | 2015-03-04 | 2019-11-20 | 国立大学法人 東京大学 | 細孔性高分子化合物、分離対象化合物の分離方法、単結晶、結晶構造解析用試料の作製方法、解析対象化合物の分子構造決定方法、及びキラル化合物の絶対配置の決定方法 |
JP6628301B2 (ja) * | 2015-03-10 | 2020-01-08 | 国立大学法人 東京大学 | 多孔性化合物の単結晶の良否判別方法、解析対象化合物を含む溶液の調製方法、結晶構造解析用試料の作製方法、及び解析対象化合物の分子構造決定方法 |
JP7049318B2 (ja) * | 2016-08-09 | 2022-04-06 | リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア | キラルな金属有機構造体における分子の配位アライメント |
US11815475B2 (en) * | 2017-03-01 | 2023-11-14 | The University Of Tokyo | Method for identifying molecular structure |
JP7141632B2 (ja) * | 2018-03-27 | 2022-09-26 | 味の素株式会社 | 極性基を有する親水性有機化合物の結晶スポンジ法による構造解析のための結晶構造解析用試料調製方法 |
EP3657159A1 (en) | 2018-11-20 | 2020-05-27 | Merck Patent GmbH | Sample holder for performing x-ray analysis on a crystalline sample, and sample holder handling system |
US20220018791A1 (en) * | 2018-11-21 | 2022-01-20 | Rigaku Corporation | Single-crystal x-ray structure analysis apparatus and method, and sample holder therefor |
JP7462872B2 (ja) * | 2018-11-21 | 2024-04-08 | 株式会社リガク | 単結晶x線構造解析装置と方法、及び、そのための試料ホルダユニット |
JP7462164B2 (ja) * | 2018-11-22 | 2024-04-05 | 株式会社リガク | 単結晶x線構造解析装置用試料ホルダ、試料ホルダユニットおよび吸蔵方法 |
US11874238B2 (en) | 2018-11-22 | 2024-01-16 | Rigaku Corporation | Single-crystal X-ray structure analysis apparatus and method, and sample holder and applicator therefor |
US20220347679A1 (en) * | 2018-11-22 | 2022-11-03 | Rigaku Corporation | Sample holder unit for single-crystal x-ray structure analysis apparatus |
JP7278526B2 (ja) * | 2018-11-22 | 2023-05-22 | 株式会社リガク | 単結晶x線構造解析システム |
CN113287004A (zh) * | 2018-11-22 | 2021-08-20 | 株式会社理学 | 单晶x射线结构解析装置和用于其的方法 |
WO2020105728A1 (ja) * | 2018-11-22 | 2020-05-28 | 株式会社リガク | 単結晶x線構造解析装置用試料ホルダユニット |
EP3885749B1 (en) | 2018-11-22 | 2025-02-19 | Rigaku Corporation | Single-crystal x-ray structure analysis apparatus and sample holder attaching device |
EP3885756B1 (en) * | 2018-11-23 | 2025-02-19 | Rigaku Corporation | Soaking machine and soaking method of sample for single-crystal x-ray structure analysis |
WO2020105723A1 (ja) | 2018-11-23 | 2020-05-28 | 株式会社リガク | 単結晶x線構造解析試料の吸蔵装置及び吸蔵方法 |
JP7462146B2 (ja) * | 2018-11-23 | 2024-04-05 | 株式会社リガク | 単結晶x線構造解析装置および試料ホルダ |
JP7015360B2 (ja) | 2019-11-01 | 2022-02-02 | キリンホールディングス株式会社 | 多成分試料における物質の構造決定方法 |
EP4063839A4 (en) | 2019-11-21 | 2023-11-22 | Kirin Holdings Kabushiki Kaisha | METHOD FOR PREPARING A CRYSTAL STRUCTURAL ANALYSIS SAMPLE FOR STRUCTURAL ANALYSIS BY CRYSTAL SPONGE METHOD |
JP2021081369A (ja) | 2019-11-21 | 2021-05-27 | キリンホールディングス株式会社 | 求核基を有する化合物の結晶スポンジ法による構造解析のための結晶構造解析用試料の調製方法 |
EP4065968A1 (en) | 2019-11-26 | 2022-10-05 | Merck Patent GmbH | Sample holder for performing x-ray analysis on a crystalline sample, and sample holder handling system |
EP3862349A1 (en) | 2020-02-10 | 2021-08-11 | Merck Patent GmbH | Hydrated crystalline polynuclear metal complex, hydrated crystalline polynuclear metal complex including a guest compound analyte and its use in a method for determining molecular structure of the guest compound analyte |
US20230096322A1 (en) * | 2020-02-10 | 2023-03-30 | Merck Patent Gmbh | Hydrated crystalline polynuclear metal complex, hydrated crystalline polynuclear metal complex including a guest compound analyte and its use in a method for determining molecular structure of the guest compound analyte |
EP4029869A1 (en) | 2021-01-15 | 2022-07-20 | Merck Patent GmbH | Solvated crystalline polynuclear metal complex solvated with a mixture of non-polar and polar solvents, such solvated crystalline polynuclear metal complex including a guest compound analyte and its use in a method for determining molecular structure of the guest compound analyte |
EP4043871A1 (en) * | 2021-02-15 | 2022-08-17 | Merck Patent GmbH | Selection method for conditions to introduce a guest analyte compound into crystalline polynuclear metal complex for use of such crystalline polynuclear metal complex including a guest compound analyte in a method for determining molecular structure of the guest compound analyte |
CN118434866A (zh) | 2021-12-27 | 2024-08-02 | 株式会社理学 | 化合物捕获用结构体 |
WO2023127850A1 (ja) | 2021-12-27 | 2023-07-06 | 株式会社リガク | 化合物捕捉用のマルチコンポーネント化された構造体 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030138940A1 (en) * | 2000-01-07 | 2003-07-24 | Lemmo Anthony V. | Apparatus and method for high-throughput preparation and characterization of compositions |
CN101319348A (zh) * | 2008-06-13 | 2008-12-10 | 青岛大学 | 倒锥形凸底式晶体生长装置 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3846522B2 (ja) | 1998-09-14 | 2006-11-15 | 独立行政法人科学技術振興機構 | 三次元かご状遷移金属錯体及びその製造法 |
PT1406641E (pt) | 2001-06-18 | 2009-04-15 | Neptune Technologies & Bioress | Extractos de krill para prevenção e/ou tratamento de doenças cardiovasculares |
JP4792219B2 (ja) | 2004-12-28 | 2011-10-12 | 国立大学法人 東京大学 | 高分子錯体 |
JP2006232738A (ja) | 2005-02-25 | 2006-09-07 | Nippon Kayaku Co Ltd | 生理活性物質リソクリバディン1及びリソクリバディン2並びにその用途 |
JP5297593B2 (ja) | 2007-03-07 | 2013-09-25 | 国立大学法人 東京大学 | 高分子錯体結晶の合成方法 |
JP5149519B2 (ja) | 2007-03-07 | 2013-02-20 | 国立大学法人 東京大学 | 高分子錯体及び高分子錯体の製造方法 |
JP5239261B2 (ja) | 2007-03-08 | 2013-07-17 | 住友化学株式会社 | 多孔性有機金属錯体、その製造方法、それを用いる不飽和有機分子の吸蔵方法及び分離方法 |
WO2009130987A1 (ja) | 2008-04-26 | 2009-10-29 | ユーエムケー・テクノロジー株式会社 | 酸化亜鉛単結晶基板の製造方法及びその方法により育成された単結晶基板並びにその基板上に成膜した半導体発光素子 |
JP2010286431A (ja) * | 2009-06-15 | 2010-12-24 | Rigaku Corp | 凍結結晶の処理装置及び処理方法 |
JP5648963B2 (ja) * | 2009-11-20 | 2015-01-07 | 国立大学法人 東京大学 | 細孔性ネットワーク錯体、ゲスト分子内包ネットワーク錯体、及びゲスト分子の分離方法 |
WO2014038221A1 (ja) * | 2012-09-07 | 2014-03-13 | 独立行政法人 科学技術振興機構 | 結晶構造解析用試料の作製方法、有機化合物の分子構造決定方法、及び結晶構造解析用試料の作製装置 |
-
2013
- 2013-03-07 WO PCT/JP2013/056371 patent/WO2014038221A1/ja active Application Filing
- 2013-03-07 EP EP13835833.8A patent/EP2894242B1/en active Active
- 2013-03-07 EP EP19188421.2A patent/EP3591103A1/en active Pending
- 2013-03-07 JP JP2014534207A patent/JP5969616B2/ja active Active
- 2013-03-07 US US14/426,809 patent/US10190952B2/en active Active
- 2013-03-07 WO PCT/JP2013/056370 patent/WO2014038220A1/ja active Application Filing
- 2013-03-08 TW TW102108219A patent/TWI501990B/zh active
- 2013-03-08 TW TW102108220A patent/TW201410315A/zh unknown
-
2018
- 2018-12-12 US US16/217,086 patent/US10684198B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030138940A1 (en) * | 2000-01-07 | 2003-07-24 | Lemmo Anthony V. | Apparatus and method for high-throughput preparation and characterization of compositions |
CN101319348A (zh) * | 2008-06-13 | 2008-12-10 | 青岛大学 | 倒锥形凸底式晶体生长装置 |
Also Published As
Publication number | Publication date |
---|---|
JP5969616B2 (ja) | 2016-08-17 |
US10684198B2 (en) | 2020-06-16 |
TWI501990B (zh) | 2015-10-01 |
US20150219533A1 (en) | 2015-08-06 |
US20190137367A1 (en) | 2019-05-09 |
EP2894242A1 (en) | 2015-07-15 |
TW201410315A (zh) | 2014-03-16 |
TW201410729A (zh) | 2014-03-16 |
US10190952B2 (en) | 2019-01-29 |
WO2014038220A1 (ja) | 2014-03-13 |
JPWO2014038220A1 (ja) | 2016-08-08 |
WO2014038221A1 (ja) | 2014-03-13 |
EP3591103A1 (en) | 2020-01-08 |
EP2894242A4 (en) | 2016-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10684198B2 (en) | Guest-compound-enveloping polymer-metal-complex crystal, method for producing same, method for preparing crystal structure analysis sample, and method for determining molecular structure of organic compound | |
Yi et al. | Synthesis and enantioseparation of chiral Au 13 nanoclusters protected by bis-N-heterocyclic carbene ligands | |
US10487420B2 (en) | Single crystal of porous compound, method for assessing quality of single crystal, method for preparing solution including compound to be analyzed, method for producing crystal structure analysis sample, and method for determining molecular structure of compound to be analyzed | |
US10309035B2 (en) | Method of preparing sample for crystal structure analysis, method of determining absolute configuration of chiral compound, and polynuclear metal complex monocrystal | |
JP7141632B2 (ja) | 極性基を有する親水性有機化合物の結晶スポンジ法による構造解析のための結晶構造解析用試料調製方法 | |
Lakshmi et al. | Synthesis, structure and spectral and electrochemical properties of 3-pyrrolyl BODIPY-metal dipyrrin complexes | |
Benda et al. | Reactivity of liquid ammonia solutions of the zintl phase K12Sn17 towards Mesitylcopper (I) and Phosphinegold (I) chloride | |
Munjal et al. | Nickel and copper complexes with few amide-based macrocyclic and open-chain ligands | |
Cerdeira et al. | Synthesis, structure and physical properties of transition metal bis 4-cyanobenzene-1, 2-dithiolate complexes [M (cbdt) 2] z−(M= Zn, Co, Cu, Au, Ni, Pd, z= 0, 1, 2) | |
Xiao et al. | Current trends and advancements in crystallization and single-crystal structural analysis of small molecules | |
Balamurugan et al. | Axial versus equatorial coordination of thioether sulfur: Mixed ligand copper (II) complexes of 2-pyridyl-N-(2′-methylthiophenyl)-methyleneimine with bidentate diimine ligands | |
Tchoń et al. | Polymorphism and resulting luminescence properties of 1-acetylpyrene | |
Poirot et al. | Luminescent fac-[ReX (CO) 3 (phenyl-pyta)](X= Cl, Br, I) complexes: influence of the halide ligand on the electronic properties in solution and in the solid state | |
Mkumbuzi et al. | Synthesis and structures of zinc and cadmium bis (dithiophosphonate) complexes | |
Süss-Fink et al. | The cluster dication [H6Ru4 (C6H6) 4] 2+ revisited: the first cluster complex containing an intact dihydrogen ligand? | |
Pramanik et al. | Coordination assembly of p-substituted aryl azo imidazole complexes: Influences of electron donating substitution and counter ions | |
Schmidbaur et al. | From gallium hydride halides to molecular gallium sulfides | |
Stone et al. | Synthesis and structural characterization of an air and water stable divalent Europium squarate prepared by in situ reduction | |
Jiang et al. | The {Cu 2 I 2} cluster bearing metal organic frameworks: crystal structures and fluorescence detecting performances towards cysteine and explosive molecules | |
Kong et al. | Effect of solvent, pH and metal ions on the self-assembly process and optical properties of an A–π–D–π–A type triphenylamine carboxylic acid derivative | |
Strelnikova et al. | Elucidating the role of the o-methoxy group in the lower rim appended salicylideneamine substituents of calix [4] arene ligands on the molecular and electronic structures of dinuclear Fe (iii)-based diamond-core complexes | |
CN106978159B (zh) | 一种具有荧光可调性质的有机-无机杂化晶体的制备方法 | |
Amato et al. | Nanostructured morphologies of complexes containing porphyrin bridges between Pt (II) acetylide tethers | |
Femoni et al. | Hetero‐Bimetallic Ni‐Rh Carbido Carbonyl Clusters: Synthesis, Structure and 13C NMR of [Ni10Rh2C (CO) 20] 2–,[Ni9Rh3C (CO) 20] 3–and [Ni6Rh8 (C2) 2 (CO) 24] 4– | |
Rutkowski et al. | Spectroscopic studies of the equilibrium between complexes of lasalocid acid with propargylamine and metal cations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20150407 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20160520 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C30B 29/58 20060101ALI20160513BHEP Ipc: C30B 29/54 20060101AFI20160513BHEP Ipc: C30B 7/06 20060101ALI20160513BHEP Ipc: C07C 13/52 20060101ALI20160513BHEP Ipc: C07D 307/92 20060101ALI20160513BHEP Ipc: C07D 311/30 20060101ALI20160513BHEP Ipc: C07D 401/14 20060101ALI20160513BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20180717 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20190329 |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
INTC | Intention to grant announced (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20191030 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602013065188 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1225223 Country of ref document: AT Kind code of ref document: T Effective date: 20200215 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20200115 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200415 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200607 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200515 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200416 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200415 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602013065188 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1225223 Country of ref document: AT Kind code of ref document: T Effective date: 20200115 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20201016 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20200331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200331 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200331 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200307 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200331 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200115 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240205 Year of fee payment: 12 Ref country code: GB Payment date: 20240205 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240208 Year of fee payment: 12 |